Letter to the Editor: Stem Cell Politics
By Richard Hayes,
New York Times
| 05. 01. 2006
To the Editor:
Re "Democrats Hope to Divide G.O.P. Over Stem Cells" (news article, April 24):
I'm a lifelong Democrat, pro-choice on abortion and in favor of stem cell research. But over-the-top promotion of this research is a mistake that could come back to bite us, and its use as a wedge issue is ill advised.
Stem cells may still prove to be a therapeutic dry hole. If successfully developed, stem cell therapies are likely to be prohibitively expensive.
Stem cell research puts women who donate eggs at significant medical risk, and could foster trafficking in eggs from poor women in developing countries.
The same stem cell technologies that might have beneficial medical applications could be used by rogue scientists intent on creating human clones and genetically modified children.
Stem cell research should be allowed, but it should proceed cautiously, under tight federal oversight.
Richard Hayes
Executive Director
Center for Genetics and Society
Oakland, Calif., April 24, 2006
Related Articles
By Alondra Nelson, Science | 09.11.2025
In the United States, the summer of 2025 will be remembered as artificial intelligence’s (AI’s) cruel summer—a season when the unheeded risks and dangers of AI became undeniably clear. Recent months have made visible the stakes of the unchecked use...
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
By Margaux MacColl, The San Francisco Standard | 09.17.2025
Designer babies are coming soon to an IVF clinic near you.
Nucleus Genomics, founded by Kian Sadeghi in 2020, when he was just 20, got its start analyzing genomes to weigh a person’s risk of everything from cancer to ADHD...
By Marianne Lamers, NEMO Kennislink [cites CGS' Katie Hasson] | 09.23.2025
Een rijtje gespreide vulva’s gaapt de bezoeker aan. Zó ziet een bevalling eruit, en zó een baarmoeder met foetus. Een zwangerschap, maar dan zonder zwangere vrouw, gestript van zorgen, gêne en pijn. De zwangerschapsmodellen en oefenbekkens, te zien in de...